186 related articles for article (PubMed ID: 34970653)
1. Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis.
Delvaux T; Jespers V; Benova L; van de Wijgert J
Front Glob Womens Health; 2021; 2():799963. PubMed ID: 34970653
[No Abstract] [Full Text] [Related]
2. Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction.
Merkatz RB; Plagianos M; Hoskin E; Cooney M; Hewett PC; Mensch BS
Contraception; 2014 Nov; 90(5):514-21. PubMed ID: 24993487
[TBL] [Abstract][Full Text] [Related]
3. The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy.
Schurmans C; De Baetselier I; Kestelyn E; Jespers V; Delvaux T; Agaba SK; van Loen H; Menten J; van de Wijgert J; Crucitti T;
BMC Public Health; 2015 Apr; 15():348. PubMed ID: 25880636
[TBL] [Abstract][Full Text] [Related]
4. High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda.
Kestelyn E; Van Nuil JI; Umulisa MM; Umutoni G; Uwingabire A; Mwambarangwe L; Uwineza M; Agaba S; Crucitti T; van de Wijgert J; Delvaux T;
PLoS One; 2018; 13(6):e0199096. PubMed ID: 29912906
[TBL] [Abstract][Full Text] [Related]
5. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
6. Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.
Ridgeway K; Montgomery ET; Smith K; Torjesen K; van der Straten A; Achilles SL; Griffin JB
Contraception; 2022 Feb; 106():16-33. PubMed ID: 34644609
[TBL] [Abstract][Full Text] [Related]
7. High acceptability and satisfaction with NuvaRing use.
Szarewski A
Eur J Contracept Reprod Health Care; 2002 Dec; 7(sup2):31-36. PubMed ID: 29243955
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
9. Attitudes Toward Menstrual Suppression Among Cyclic and Continuous Contraceptive Vaginal Ring Users in Kenya.
Walker KW; Mugo N; Ngure K; Gakuo S; Casmir E; Wiener H; Long D; Shrestha S; Marrazzo J
J Family Reprod Health; 2023 Sep; 17(3):118-127. PubMed ID: 38716295
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing.
Novák A; de la Loge C; Abetz L
Pharmacoeconomics; 2004; 22(4):245-56. PubMed ID: 14974874
[TBL] [Abstract][Full Text] [Related]
11. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
12. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
13. Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Jackanicz T
Contraception; 1997 Oct; 56(4):233-9. PubMed ID: 9408704
[TBL] [Abstract][Full Text] [Related]
14. An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose).
Gill K; Happel AU; Pidwell T; Mendelsohn A; Duyver M; Johnson L; Meyer L; Slack C; Strode A; Mendel E; Fynn L; Wallace M; Spiegel H; Jaspan H; Passmore JA; Hosek S; Smit D; Rinehart A; Bekker LG
J Int AIDS Soc; 2020 Oct; 23(10):e25626. PubMed ID: 33034421
[TBL] [Abstract][Full Text] [Related]
15. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
Mauck C; Glover LH; Miller E; Allen S; Archer DF; Blumenthal P; Rosenzweig A; Dominik R; Sturgen K; Cooper J; Fingerhut F; Peacock L; Gabelnick HL
Contraception; 1996 Jun; 53(6):329-35. PubMed ID: 8773419
[TBL] [Abstract][Full Text] [Related]
16. High acceptability and satisfaction with NuvaRing use.
Szarewski A
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():31-6; discussion 37-9. PubMed ID: 12659400
[TBL] [Abstract][Full Text] [Related]
17. Non-adherence among women enrolled in a contraceptive vaginal ring use study in Kisumu, Kenya, 2014-2015.
McLellan-Lemal E; Gvetadze R; Desai MA; Makanga EM; Pan Y; Haaland RE; Holder AN; Mudhune V; Williams T; Samandari T
J Glob Health Rep; 2018; 2():. PubMed ID: 30976663
[TBL] [Abstract][Full Text] [Related]
18. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis.
Griffin JB; Ridgeway K; Montgomery E; Torjesen K; Clark R; Peterson J; Baggaley R; van der Straten A
PLoS One; 2019; 14(11):e0224898. PubMed ID: 31703094
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring.
Stifani BM; Plagianos M; Vieira CS; Merkatz RB
Contraception; 2018 May; 97(5):415-421. PubMed ID: 29269252
[TBL] [Abstract][Full Text] [Related]
20. The hormonal ring. A new contraceptive gains acceptance.
Hardy EE; Reyes Q; Gomez F; Portes-carrasco R; Faundes A
IDRC Rep; 1984 Jul; 13(2):11. PubMed ID: 12313242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
